BNET Industries
Last Fiscal Year Sales:$17.5M
- Private
- US
Dow Jones Description
Jackson ImmunoResearch Laboratories, Inc. specializes in the production and conjugation of affinity-purified, secondary antibodies and purified immunoglobulins. Our products are sold primarily to scientists in universities and research institutes throughout the world who are conducting research in the plant, animal, and biomedical sciences. The company is located in rural Pennsylvania, near the Amish country, about 40 miles west of Philadelphia. It was started in 1982 by scientists whose education and previous experience included research in cell biology, protein chemistry, microbiology, and product development in immunology. Our goal is to provide other scientists with the newest, largest selection of, and highest quality of secondary reagents, with the best technical and customer services possible. The products are for research use only, and not for diagnostics or therapeutics. They are not primary antibodies, nor are they medical devices.
President and CEO
William Jackson StegemanNumber of Employees 74
Contact Information
872 W Baltimore Pike
West Grove, Pennsylvania 19390
1 610 869 4024
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Decision Makers
| Name (plus bio) | Position |
|---|---|
| William Jackson Stegeman | President and CEO |
| Sue Hallett | Managing Director |
| Organization | Position | Status |
|---|---|---|
| Jackson Immunoresearch Laboratories, Inc. | President and CEO | Current |
| Organization | Position | Status |
|---|---|---|
| Jackson Immunoresearch Laboratories, Inc. | Managing Director | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes


